Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 58%
Hold 0%
Sell 0%
Strong Sell 8%

Bulls say

HealthEquity is a leading provider of healthcare savings and spending solutions, with a strong and growing market opportunity and a growing customer base. With its digitized platform and expanding customer offerings, the company is poised to generate strong revenue growth and margin expansion. The regulatory landscape is also improving for the company, which could lead to further market expansion potential. The company's strong financials, investment in technology, and strategic positioning make it an attractive investment opportunity.

Bears say

HealthEquity is facing increased competition in the healthcare savings and spending decisions market, with health reimbursement arrangements and health savings accounts as the main sources of revenue. Despite the company's strong growth rate and expanding market share, there are concerns over potential data breaches and fraud, as well as the company's reliance on the unstable labor market. This, coupled with regulatory uncertainties, may affect HSA eligibility expansion and hinder the company's growth potential.

HealthEquity (HQY) has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 58% recommend Buy, 0% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 12 analysts, HealthEquity (HQY) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.